Organigram Global (OGI) Return on Capital Employed (2019 - 2021)

Organigram Global (OGI) posted quarterly Return on Capital Employed of 54.89% for Q1 2021, up 39.02% quarter-over-quarter from 90.01% in Q4 2020.

Organigram Global (OGI) Return on Capital Employed (2019 - 2021) Analysis & Trends

Organigram Global (OGI) has reported Return on Capital Employed for 3 consecutive years, with 54.89% the latest figure, recorded in Q1 2021.

In Q1 2021, Return on Capital Employed changed N/A year-over-year to 54.89%; the TTM figure through Feb 2021 stood at 54.89% (changed N/A YoY), while the FY2025 annual figure was 4.24%, up 725.0% from the prior year.
Return on Capital Employed grew to 54.89% in Q1 2021 per OGI's latest filing, from 90.01% in the prior quarter.
Across five years, Return on Capital Employed topped out at 4.4% in Q3 2019 and bottomed at 90.01% in Q4 2020.
Historically, Return on Capital Employed has averaged 48.89% across 3 years, with a median of 54.89% in 2021.
On a YoY basis, Return on Capital Employed climbed as much as 8731 bps in 2020 and fell as far as 8731 bps in 2020.
Organigram Global's Return on Capital Employed stood at 4.4% in 2019, then tumbled by 2144 bps to 90.01% in 2020, then surged by 39 bps to 54.89% in 2021.
Business Quant data shows OGI's Return on Capital Employed at 54.89% in Q1 2021, 90.01% in Q4 2020, and 82.91% in Q3 2020.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	ROCE (Qtr)
1	Haleon	43.94 Bn	42.97 Bn	-	-
2	Teva Pharmaceutical Industries	43.08 Bn	39.43 Bn	2.15 Bn	6.60%
3	Zoetis	31.54 Bn	29.87 Bn	1.05 Bn	17.16%
4	Takeda Pharmaceutical	28.60 Bn	22.80 Bn	5.10 Bn	6.07%
5	United Therapeutics	22.12 Bn	19.46 Bn	683.80 Mn	22.04%
6	Viatris	18.75 Bn	17.86 Bn	1.46 Bn	-0.29%
7	Neurocrine Biosciences	15.50 Bn	15.11 Bn	935.80 Mn	18.67%
8	Elanco Animal Health	11.69 Bn	11.16 Bn	798.00 Mn	5.52%
9	Dr Reddys Laboratories	10.13 Bn	9.96 Bn	-	-
10	Organigram Global	150.66 Mn	150.54 Mn	28.97 Mn	-

Download Data